EE. UU. se FDA Joins Global Regulators to Investigate Contaminated Cough Syrup 1 Hour Ago
Delhi to win Padma Shri award 7 hours ago
February 25, 2022
February 25, 2022
November 25, 2022
October 1, 2021
Restart consciousness
The Unsung Hero of Holistic Recovery
Technological disruption in Indian healthcare and pharmaceuticals
Are you ready for the challenge?
Holistic solutions for a healthier India
Adopt dynamic technologies
More than 125,000 industry leaders read it every day
Sun Pharmaceutical Industries Limited, India’s largest drugmaker, said on Thursday it will acquire U. S. -based Concert Pharmaceuticals. The U. S. Department of Homeland Security for $576 million to gain access to its experimental drug for the remedy of asymmetric baldness. drug maker Ranbaxy Laboratories Ltd worth $3200 million in 2014, according to Refinitiv data.
The startling revelations are made through the Indian Council of Medical Research (ICMR) and the Central Standard Drug Control Organization (CDSCO) in RTI’s reaction to Pune businessman Prafful Sarda.